MD Anderson treats more patients with MCL than any other cancer center in the U.S.
In 2014, Kinder Foundation committed $1 million to M.D. Anderson Cancer Center to advance studies that develop more effective, durable treatments. The gift supported the research led by Michael Wang, M.D., professor in Lymphoma/Myeloma and director of M.D. Anderson Cancer Center’s MCL Program of Excellence.
Information on page is current as of August 22, 2025. Lifetime gift total of $4,458,586 may include other gifts not mentioned above.
mdanderson.orgNews & Press
- MD Anderson Board of Visitors welcomes new members, honors new Life Member —MD Anderson
- Study shows MD Anderson-developed drug effective in overcoming ibrutinib resistance in mantle cell lymphoma —EurekAlert!
- Rich Kinder tells all at record-breaking M.D. Anderson fundraiser —Houston Business Journal
- ‘A Conversation with A Living Legend’ reveals 5 things we didn’t know about Rich Kinder —CultureMap
- Reluctant billionaire steps out of his comfort zone to help raise record amount for vital hospital —PaperCity Magazine
- Rich Kinder gets candid, helps raise record $1.3 million for MD Anderson Cancer Center —Houston Chronicle
- Mantle Cell Lymphona Research At MD Anderson Gets $1 Million Donation From Kinder Foundation —BioNews Texas
- Kinder Foundation commits $1 million for mantle cell lymphoma resesearch —Press Release
- Kinder Foundation donates $1M to M.D. Anderson Cancer Center —Houston Business Journal